Mallinckrodt News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

15.11.23	Mallinckrodt Completes Financial Restructuring and Irish Examinership Proceedings and Emerges From Chapter 11 (PR Newswire)
08.11.23	Mallinckrodt to Present Breadth of Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Association for the Study of Liver Diseases (AAS... (PR Newswire)
01.11.23	Mallinckrodt to Present Data on TERLIVAZ® (terlipressin) for Injection in Adult Patients with Hepatorenal Syndrome (HRS) at the American Society of Nephrology (ASN) Kidney Week 2023 Scientific Meeting (PR Newswire)
10.10.23	Mallinckrodt plc (in examinership) Receives U.S. Court Approval for Financial Restructuring Plan (PR Newswire)
31.08.23	Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD) (PR Newswire)
30.08.23	Mallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing Operations (PR Newswire)
28.08.23	Mallinckrodt Initiates Voluntary Prepackaged Chapter 11 Proceedings In U.S. Bankruptcy Court (RTTNews)
28.08.23	Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations (PR Newswire)
23.08.23	Mallinckrodt To Initiate Chapter 11 Bankruptcy Proceedings (RTTNews)
23.08.23	Mallinckrodt Inks RSA To Initiate Voluntary Prepackaged Chapter 11 Proceedings (RTTNews)
23.08.23	Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan (PR Newswire)
23.05.23	Pre-market Movers: BIOC, MVLA, COYA, PACW, OMH… (RTTNews)
09.05.23	Mallinckrodt plc Reports First Quarter 2023 Financial Results and Reaffirms Full Year Guidance (PR Newswire)
17.04.23	ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK (PR Newswire)
14.04.23	ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK (PR Newswire)
07.04.23	ROSEN, LEADING INVESTOR COUNSEL, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK (PR Newswire)
28.03.23	ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK (PR Newswire)
22.03.23	GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Mallinckrodt plc Investors to Inquire About Securities Class Action Investigation - MNK (PR Newswire)
28.02.23	Mallinckrodt plc Reports Fourth Quarter and Fiscal 2022 Financial Results and Provides 2023 Guidance (PR Newswire)
08.02.23	Mallinckrodt to Report Earnings Results for Fourth Quarter 2022 (PR Newswire)
12.01.23	Mallinckrodt Announces Appointment of Dr. Peter Richardson, MRCP, as Chief Scientific Officer (PR Newswire)
08.11.22	Mallinckrodt plc Reports Third Quarter 2022 Financial Results and Reaffirms Guidance (PR Newswire)
24.10.22	Mallinckrodt Receives Approval to List on NYSE American (PR Newswire)
06.10.22	Mallinckrodt Announces Appointment of Susan Silbermann to its Board of Directors (PR Newswire)
28.09.22	Mallinckrodt Announces Submission of 510(k) to the U.S. FDA for Inhaled Nitric Oxide Delivery System (PR Newswire)
15.09.22	Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin) for injection for the Treatment of Hepatorenal Syndrome (HRS) (PR Newswire)
11.08.22	Mallinckrodt plc Reports Second Quarter 2022 Financial Results and Provides 2022 Financial Guidance (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	508.50	0.39 %	K V
CieFinRichemont	138.40	-0.07 %	K V
Nestle	73.82	-0.30 %	K V
Givaudan	3’880.00	-0.41 %	K V
Swiss Life Hldg	699.60	-0.48 %	K V
ABB	48.45	-1.62 %	K V
UBS Group	29.28	-1.68 %	K V
Lonza Grp	542.00	-2.17 %	K V
Part Grp Hldg	1’284.50	-2.39 %	K V
Holcim	84.60	-3.51 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Mallinckrodt PLC Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten